MedTrace Logo

The 36-month Extension to Follow up Sub Study

NCT01615692 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-04-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate leg health for one additional year in patients with symptomatic proximal deep venous thrombosis who did not already develop Post-Thrombotic Syndrome (PTS) during the 2 years of follow up in the SOX Trial.

Conditions

  • Postphlebitic Syndrome
  • Post-Thrombotic Syndrome
  • Deep Vein Thrombosis

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • Sigvaris Corporation

    collaborator INDUSTRY

  • Sir Mortimer B. Davis - Jewish General Hospital

    lead OTHER

Principal Investigators

  • Susan R. Kahn, M.D., M.Sc. · Sir Mortimer B. Davis - Jewish General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01615692 on ClinicalTrials.gov